Abstract
Purpose of the ReviewThis summarizes the major trials from the past year examining percutaneous coronary intervention (PCI) strategies and adjunct therapies in myocardial infarction.Recent FindingsSignificant progress has been made in four areas: (1) mechanical circulatory support in acute myocardial infarction with cardiogenic shock – trials demonstrate that a percutaneous left ventricular assist device provides a significant mortality benefit in select patients. (2) Timing and choice of complete revascularization in patients with MI without shock – trials support earlier complete revascularization during the index procedure or hospitalization. (3) Intravascular imaging – trials highlight that using optical coherence tomography or intravascular ultrasound yields superior outcomes compared to angiographic guidance alone. (4) Dual Antiplatelet Therapy (DAPT) timing – findings indicate that stopping DAPT earlier (within 1–3 months post-PCI) and transitioning to P2Y12 inhibitors is generally safe and effective.SummaryRecent trials underscore the evolving role of advanced technologies and optimized timing in improving outcomes for MI patients, with a focus on individualized and evidence-based care strategies.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call